主動脈瘤市場規模、佔有率、成長分析、按類型、按治療方法、按產品、按最終用途、按地區 - 行業預測，2025-2032

2023 年全球主動脈瘤 (AA) 市場規模價值為 41.2 億美元，預計將從 2024 年的 45.2 億美元成長到 2032 年的 95.6 億美元，預測期內（2025-2032 年）的複合年成長率為 9.8%。

市場動態受到人口老化加劇、動脈硬化（尤其是心血管疾病）盛行率上升以及不健康的生活方式的影響。光是在美國，老年人口預計將從目前的5,400萬人增加到2040年的8,080萬人，到2060年將增加至9,470萬人，這將擴大需要主動脈瘤治療的患者數量。有關醫療保險報銷的優惠規定以及對血管支架主動脈修復（EVAR）等微創手術的需求激增，進一步推動了市場成長。這些手術具有失血量減少、切口更小、恢復更快、療效更佳等優點，因此越來越有吸引力。此外，吸菸仍然是一個重要的危險因素，尤其是在老年人中，影響主動脈瘤的進展和手術結果。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 技術進步
• 監管格局
• 專利分析

主動脈瘤市場規模（按類型）

• 市場概況
• 胸主動脈瘤（TAA）
• 腹部主動脈血管瘤(AAA)

主動脈瘤市場規模：依治療方法

• 市場概況
• 開放性手術(OSR)
• 血管支架置換術 (EVAR)

主動脈瘤市場規模：依產品

• 市場概況
• 血管支架
• 導管
• 其他

主動脈瘤市場規模：依最終用途

• 市場概況
• 醫院
• 門診手術中心（ASC）
• 其他

主動脈瘤市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Medtronic（USA）
• WL Gore & Associates, Inc.（USA）
• Cook Medical（USA）
• Terumo Corporation（Japan）
• Cardinal Health（USA）
• Endologix, LLC（USA）
• Lombard Medical（UK）
• CryoLife, Inc.（USA）
• MicroPort Scientific Corporation（China）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Becton, Dickinson and Company（USA）
• Braun Melsungen AG（Germany）
• Getinge AB（Sweden）
• Merit Medical Systems, Inc.（USA）
• Terumo Aortic（UK）
• Biotronik SE & Co. KG（Germany）
• Medtronic Vascular, Inc.（USA）

結論和建議

Global Aortic Aneurysm Market size was valued at USD 4.12 billion in 2023 and is poised to grow from USD 4.52 billion in 2024 to USD 9.56 billion by 2032, growing at a CAGR of 9.8% during the forecast period (2025-2032).

Market dynamics are significantly influenced by the growing aging population and the rising prevalence of atherosclerosis, particularly with an increasing incidence of cardiovascular diseases and unhealthy lifestyle choices. In the U.S. alone, the elderly demographic is expected to rise from 54 million today to 80.8 million by 2040 and 94.7 million by 2060, expanding the patient base for aortic aneurysm (AA) repairs. Favorable health reimbursement regulations and a surge in demand for minimally invasive procedures, such as Endovascular Aneurysm Repair (EVAR), further bolster market growth. These procedures offer advantages such as reduced blood loss, smaller incisions, quicker recovery, and improved outcomes, making them increasingly attractive. Additionally, smoking remains a significant risk factor, especially in older adults, affecting AA progression and surgical outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aortic Aneurysm market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Aortic Aneurysm Market Segments Analysis

Global Aortic Aneurysm Market is segmented by Type, Treatment, Product, End-Use and region. Based on Type, the market is segmented into Thoracic Aortic Aneurysm (TAA) and Abdominal Aortic Aneurysm (AAA). Based on Treatment, the market is segmented into Open Surgical Repair (OSR) and Endovascular Aneurysm Repair (EVAR). Based on Product, the market is segmented into Stent Grafts, Catheters and Others. Based on End-Use, the market is segmented into Hospitals, Ambulatory Surgery Centers (ASCs) and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Aortic Aneurysm Market

The Global Aortic Aneurysm market is primarily driven by the escalating number of aortic aneurysm cases, especially among the elderly demographic. This rise can be attributed to various risk factors, including hypertension, smoking, and atherosclerosis, which collectively elevate the occurrence of these conditions. As the prevalence of aortic aneurysms continues to grow, there is an urgent demand for advanced diagnostic tools and effective treatment options to manage and address these life-threatening issues. Consequently, the increasing awareness and need for improved healthcare solutions in this area are significantly propelling the market forward.

Restraints in the Global Aortic Aneurysm Market

One of the primary challenges facing the global aortic aneurysm market is the prevailing lack of awareness regarding the condition among both the general public and healthcare professionals. This widespread unawareness can lead to underdiagnosis, which in turn results in delayed treatment and, ultimately, unfavorable patient outcomes. Such issues not only compromise the health of individuals affected by aortic aneurysms but also significantly impede the overall growth of the market. Addressing this knowledge gap is essential for improving diagnosis rates and treatment efficacy, thereby fostering a more robust market environment.

Market Trends of the Global Aortic Aneurysm Market

The Global Aortic Aneurysm market is witnessing significant growth, driven by advancements in minimally invasive surgical techniques, increasing awareness of vascular diseases, and a rising geriatric population susceptible to aortic aneurysms. The development and adoption of innovative medical devices, such as endovascular stent grafts, along with improvements in diagnostic imaging technologies, are propelling market expansion. Additionally, an increasing focus on research and development activities to enhance patient outcomes is contributing to market dynamics. This trend is further supported by the growing prevalence of risk factors such as hypertension and smoking, underscoring the urgency for effective treatment options in the healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Advancement
• Regulatory Landscape
• Patent Analysis

Global Aortic Aneurysm Market Size by Type & CAGR (2025-2032)

• Market Overview
• Thoracic Aortic Aneurysm (TAA)
• Abdominal Aortic Aneurysm (AAA)

Global Aortic Aneurysm Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Open Surgical Repair (OSR)
• Endovascular Aneurysm Repair (EVAR)

Global Aortic Aneurysm Market Size by Product & CAGR (2025-2032)

• Market Overview
• Stent Grafts
• Catheters
• Others

Global Aortic Aneurysm Market Size by End-Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgery Centers (ASCs)
• Others

Global Aortic Aneurysm Market Size & CAGR (2025-2032)

• North America (Type, Treatment, Product, End-Use)
  • US
  • Canada
• Europe (Type, Treatment, Product, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Treatment, Product, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Treatment, Product, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Treatment, Product, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W.L. Gore & Associates, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endologix, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lombard Medical (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Aortic (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Vascular, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations